Supplementary Figure S1 from Clinical and molecular features of long-term response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancer | Synapse
September 16, 2024
Supplementary Figure S1 from Clinical and molecular features of long-term response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancer
Key Points
Key points are not available for this paper at this time.
Abstract
Frequency of patients with long-term response (LTR), short-term response (STR), and progressive disease (PD) from individual clinical sites.
Ask AI
Helpful
Bookmark
Share
Ask AI
Helpful
Bookmark
Share
Cite This Study
Thummalapalli et al. (Mon,) studied this question.